ResearchNurses.co, a UK-based research nurses provider, has been awarded a contract with Nottingham University Hospitals Research and Innovation Department to provide research nursing services for clinical trials related to multiple sclerosis (MS).
As part of the project, research nurses will work alongside three major pharmaceutical sponsors as well as the MS Society in clinical trials for patients with relapsing-remitting MS and secondary progressive MS.
ResearchNurses.co will be working with some of the country’s leading neurologist consultants and investigators at the hospital including Professor Chris Constantinescu, Dr Bruno Gran and Dr Nikos Evangelou.
Dr Maria Koufali, Deputy Director for Research & Innovation at Nottingham University Hospitals said: “These studies are of huge importance to everyone affected by multiple sclerosis and we are keen to offer them to as many patients as possible. This will ensure patient access to innovative medicines but also improvement of our MS clinical services.
“ResearchNurses.co have been extremely quick and efficient at responding to our needs and have demonstrated that they are able to provide a wide-ranging and reliable service, helping us to ensure the integrity of our trial data as well as ensuring trial participants are comfortable throughout the study.”
Based at Nottingham’s Queens Medical Center, ResearchNurses.co will liaise with key sponsors and investigators to oversee and provide drug infusions and venepuncture, as well as providing processing and monitoring services.
John Illingworth, managing director of ResearchNurses.co added: “Many of our clients require nursing assistance and on-site support, our research nurses have extensive experience in fitting into existing team structures as well as expert knowledge of key protocols allowing them to provide a tailor made service and additional resource where it matters most.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.